Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06318273
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-13
Brief Title:
A Study to Assess Adverse Events and How Intravenously IV Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-13
First Submit QC Date:
March 13 2024
Study First Post Date:
2024-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL